Serum uric acid is associated with non-dipping circadian pattern in young patients (30–40 years old) with newly diagnosed essential hypertension
Francesco GiallauriaP PredottiAntonio CascielloA GriecoAngelo RussoAnna ViggianoRodolfo CitroAmelia RaveraMaurizio CiardoMichele GuglielmiMarcello MaggioCarlo Vigorito
13
Citation
49
Reference
10
Related Paper
Citation Trend
Abstract:
Background: We aimed at evaluating the relationship between the circadian blood pressure rhythm and UA level in young patients (30–40 years old) with newly diagnosed essential hypertension. Methods: The study included 62 essential hypertensive patients and 29 healthy controls (20 men, 35 ± 3 years) divided into two groups according to 24-hour ABPM resuts: 30 dippers and 32 nondippers. Results: Nondippers showed significantly higher both serum UA levels compared to dippers and controls (6.1 ± 0.7, 5.2 ± 0.9 and 4.1 ± 0.9 mg/dL, p < 0.001, respectively); and high sensitivity C-reactive protein (hsCRP) (4.1 ± 2.2 mg/L, 3.3 ± 1.9 mg/L, and 1.4 ± 0.9 mg/L, p < 0.001, respectively). After adjusting for age, sex, body mass index, smoking, creatinine levels, hsCRP and comorbidity, multivariate logistic regression analysis revealed an independent association between serum UA levels and nondipper pattern (OR 2.44, 95%CIs 1.4–4.1, p = 0.002). Conclusion: Serum UA is independently associated with nondipper circadian pattern in young patients with newly diagnosed essential hypertension.Keywords:
Essential hypertension
Idiopathic hyperuricemia is generally defined as hyperuricemia caused by unknown origin. Idiopathic hyperuricemia is categorized as overproducing or underexcretion of uric acid. Overproduced uric acid is caused by increased biosynthesis of purine bodies, hypermetabolization of purine bodies, or increased intake of dietary purine bodies. Idiopathic hyperuricemia with overproducing uric acid can be diagnosed by amount of excreted uric acid in the urine. Recently it has been identified that hypertension are frequently associated with myogenic hyperuricemia converted from overproduced hypoxanthine in the skeletal muscles. Some anti-hypertensive drugs including alpha1 blocker, ACE inhibitor, alphabeta blocker, or long-acting Ca blocker attenuated the myogenic hyperuricemia. Thus, these drugs may be helpful in the management of hypertension with hyperuricemia.
Hypoxanthine
Purine metabolism
Allopurinol
Cite
Citations (2)
There are two reasons for the high level of serum uric acid,which induces hyperuricemia.Excessive uricogenesis is considered to be one of the risk factors.Xanthine oxidase is the main drug therapy target in hyperuricemia,which is one of the key enzymes conducting the metabolism of uric acid.The lack of excretion is another reason for the excessive level of uric acid.Uric acid transport is achieved by various kinds of transporters expressed in the membranes of the renal tubular epithelial cells.Gene mutations or deletions of the transporters are the main reasons for abnormal serum uric acid level.Gene expression regulations of these transporters by relevant drugs are the main method to conduct the excretion of uric acid.In this paper,recent advances in the study of the drug therapy targets have been reviewed in those two aspects.
Xanthine
Cite
Citations (0)
Objective To evaluate a possible relationship between hyperuricemia (HUA) and meta -bolic syndrome (MS).Methods The prevalence rates of UA and MS were calculated and analyzed in 1278 persons who underwent health check up.Analysis was carried out on the blood uric acid and parameters of MS, and a multiple regression analysis was performed on blood uric acid and HOMA-IR. Results (1) The prevalences of obesity,high WHR, high IFG, HBP,HTG,HTC were significantly higher in high uric acid group that in normal uric acid group.(2)The blood uric acid was positively correlated with HOMA-IR. (3) The prevalence of high uric acid in MS group was significantmy higher than that in the group without MS. Conclusion High uric acid level may be an important factor for development and progress of MS.
Cite
Citations (0)
AIM To establish hyperuricemia animal model. METHODS The mice were given uric acid by ip and then the level of uric acid in serum was detected. RESULTS Uric acid 125,250,500, 1 000 mg·kg -1 ip significantly increased the level of uric acid in mouse serum. The level of uric acid in mouse serum was attained peak at 10 min and the hyperuricemia could lasted over 4 hours after uric acid 250 mg·kg -1 given. CONCLUSION Uric acid given by ip can form mouse hyperuricemia model, the dosage of 250 mg·kg -1 is better.
Animal model
Cite
Citations (5)
Uric acid as the end-product of purine metabolism in human body is excreted through kidney. If the production of uric acid surpasses the level that excreted by kidney, the serum level of uric acid will increase and hyperuricemia will occur. Hyperuricemia is associated with the development and progression of gout, cardiovascular diseases, tumor lysis syndrome and renal disease. Therefore, clinical significance of serum uric acid was summarized in this article.
Purine metabolism
Cite
Citations (6)
Cite
Citations (34)
Uric acid is an antioxidant in the extracellular environment, while it has prooxidative effects inside the cell. It is thought that antioxidative effects of uric acid may be protective, particularly in neurological diseases. While prooxidative effects of uric acid has a leading role in the development and progress of chronic kidney disease, metabolic syndrome and cardiovascular diseases. Uric acid is more than a product of purine metabolism. The uric acid paradox indicates that uric acid may play a central role in many diseases. This article was tried to review the researches and clinic studies of hyperuricemia from the viewpoint of the inflammation in recent years.
Key words:
Uric acid; Inflammatory; Oxidation; Antioxidant
Purine metabolism
Cite
Citations (0)
Hyperuricemia is a common metabolic syndrome. Elevated uric acid levels are risk factors for gout, hypertension, and chronic kidney diseases. Furthermore, various epidemiological studies have also demonstrated an association between cardiovascular risks and hyperuricemia. In hyperuricemia, reactive oxygen species (ROS) are produced simultaneously with the formation of uric acid by xanthine oxidases. Intracellular uric acid has also been reported to promote the production of ROS. The ROS and the intracellular uric acid itself regulate several intracellular signaling pathways, and alterations in these pathways may result in the development of atherosclerotic lesions. In this review, we describe the effect of uric acid on various molecular signals and the potential mechanisms of atherosclerosis development in hyperuricemia. Furthermore, we discuss the efficacy of treatments for hyperuricemia to protect against the development of atherosclerosis.
Pathogenesis
Cite
Citations (184)
Urea is the main product secreted in normal human urine, which will contain a small amount of uric acid.Uric acid is the end product of purines known as trioxypurines, which have a weakly acidic alcoholic form, and if purines are metabolized, the risk of hyperuricemia will be increased. It has been shown that the risk of developing CKD in patients with increased serum uric acid levels is 2.21 times that of normal patients. There are experimental data to divide patients into two groups, one is patients with hyperuricemia and the other is patients with normal serum uric acid, the results of the study show that patients with hyperuricemia have a significantly greater probability of developing acute kidney injury than patients with normal serum uric acid, and most of them need kidney replacement therapy. This review focuses on the development of kidney damage in hyperuricemia.
Purine metabolism
Cite
Citations (1)